Medical device company Levita Magnetics has announced that the first ever robotic-assisted gallbladder removal procedures have been performed using its surgical platform.
The Levita Robotic Platform has been used in a reduced-incision laparoscopic cholecystectomy, gallbladder removal, at Clínica INDISA in Santiago, as part of a current clinical study of the system in Chile.
Levita’s magnetic platform is designed to improve visualisation, maintain surgeon control of instruments, and increase hospital efficiency with fewer assistive personnel required to conduct the procedures. It is also intended to deliver less pain, faster recovery, and fewer scars for patients.
With its compact footprint, the robotic platform is designed for high volume ambulatory or same-day discharge abdominal surgeries. The aim is to increase the volume of performed procedures while improving surgical access to patients.
“We are taking magnetic surgery to the next level with this disruptive approach,” said Alberto Rodriguez-Navarro, CEO of Levita Magnetics.
“Our robotic platform is designed to be the first to enable the clinical benefits of a less invasive procedure with fewer incisions, while allowing the surgeon full control of the platform and surgical instruments directly beside the patient.
“We believe enabling timely access to needed surgery has a direct impact on the quality of life for patients and may reduce the risk of complications or death due to the underlying disease.
“Our ultimate goal is to globally increase the ability of surgeons and hospitals to provide more patients access to better surgical procedures within their communities.”
The company is now working on further clinical studies and plan to submit the Levita Robotic Platform to the U.S. FDA for clearance in late 2021.
